Last reviewed · How we verify
NCT04046042: VRI
Virtual Reality Intradialysis: Last vs. First Part of the Session
NA trial testing Conventional exercise in End Stage Renal Disease on Dialysis in 50 participants. Currently enrolling.
29 August 2024
Quick facts
| Lead sponsor | Cardenal Herrera University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 2 September 2019 |
| Primary completion | 29 August 2024 |
| Estimated completion | 30 August 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Conventional exercise
- Exercise during the last two hours of the hemodialysis session
Conditions studied
- End Stage Renal Disease on Dialysis — all drugs for End Stage Renal Disease on Dialysis →
- Hemodialysis Complication — all drugs for Hemodialysis Complication →
Sponsor
Cardenal Herrera University
Who can join
18 and older, any sex, with End Stage Renal Disease on Dialysis or Hemodialysis Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this investigation is to assess if an intradialysis virtual reality exercise program during the last two hours of the hemodialysis session results in greater hemodynamic stability than exercise performed during the first two hours of the hemodialysis session. The secondary aims are to assess the impact of intradialysis virtual reality exercise during the last two hours of the hemodialysis session on dialysis efficacy, postdialysis molecules rebound, adherence to exercise, functional capacity, physical activity level, health-related quality of life, cognitive function, morbidity, frailty and dependency. We will also analyze the reliability of muscle strength assessment of lower limb muscles with a handheld dynamometer during hemodialysis.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Impact of COVID-19 Pandemic on Health-Related Quality of Life and Physical Activity of Patients in Hemodialysis.
Segura-Ortí E, Martínez-Olmos FJ, Ródenas-Pascual Á, Guillem-Giménez E, et al · · 2022 · cited 8× · PMID 36360558 · DOI 10.3390/healthcare10112217 -
A Current State of the Art and Science of Exercise in Dialysis: A Narrative Review.
Borkum M, Levin A, Ficocelli J, Wone L, et al · · 2024 · cited 1× · PMID 38370309 · DOI 10.1177/20543581241229253 -
The Effect of Intradialytic Exercise Using Virtual Reality on the Body Composition of Patients with Chronic Kidney Disease
Romeu-Perales M, Segura-Ortí E, Cana-Poyatos A, Toquero-Correa M, et al · · 2024
Verify or expand the search:
- PubMed search for NCT04046042
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Conventional exercise
Trials testing the same drug.
- NCT06978582 — Effectiveness and Safety of a Tele-Rehabilitation Program on Fatigue and Related Variables in Chronic Fatigue Syndrome a · NA · active not recruiting
- NCT06807411 — Effectiveness of Video-Based Upper Extremity Exercise Program in Parkinson's Disease · NA · completed
- NCT06800014 — Effectiveness of Wearable Trackers and Telerehabilitation in Cerebral Palsy · NA · completed
- NCT05482646 — Tai Chi Versus Conventional Exercise to Alleviate Depression in Insomniacs · NA · completed
- NCT04539522 — Efficacy of a Three-dimensionally Corrective Exercise Therapy for Scoliosis · NA · unknown
Other recruiting trials for End Stage Renal Disease on Dialysis
Currently open trials in the same condition.
- NCT07053462 — CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk · Phase 1, PHASE2 · recruiting
- NCT07016841 — Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins · recruiting
- NCT05654103 — Comparing Surgical and Endovascular Arteriovenous Fistula Creation · NA · recruiting
- NCT06483074 — Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients · Phase 2 · recruiting
- NCT06249932 — Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease · Phase 4 · recruiting
Other Cardenal Herrera University trials
Trials by the same sponsor.
- NCT07471269 — Online Pain Neuroscience Education For Fear Of Childbirth. · NA · recruiting
- NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
- NCT07499856 — Intradialytic Exercise Program Supported by Audiovisual Media Combined With Mindfulness · NA · enrolling by invitation
- NCT07275112 — Cross-cultural an Reliability and Validity Evaluation of TENDINS-A in Spain · completed
- NCT07133581 — Design and Validation of FEXO: A Playful Exercise Program for Institutionalized Frail Older Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04046042 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardenal Herrera University
- Last refreshed: 14 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04046042.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing